Structure-guided identification of a PrPC-binding peptide derived from Brucella abortus Hsp60 for receptor-mediated mucosal targeting

Key Points

• The study identifies a novel prpc-binding peptide, enhancing targeted delivery techniques for therapeutics.
• Structural analysis shows strong interaction between the peptide and prpc, indicating effective binding properties.
• The approach utilized a combination of structural and binding assays to characterize the peptide's interaction with prpc.
• These findings may enable innovative strategies for mucosal vaccination, enhancing immunological responses.